Clinical Studies on Generic Drug Efficacy: What the Research Really Shows
February 28 2026
Tag: biosimilars
21 Mar
Global Biosimilar Markets: Europe vs United States
Europe led the world in biosimilar adoption since 2006, while the U.S. lagged due to legal and regulatory hurdles. Now, with FDA rule changes and patent expirations, the U.S. market is accelerating rapidly. Both regions are saving billions in healthcare costs.
Read More...
23 Dec
Insurance Changes and Generic Switching: Navigating Formulary Updates in 2025
In 2025, Medicare Part D formularies are shifting hard toward generics and biosimilars to cut costs. Learn what drugs are being swapped, how to fight exclusions, and how to save thousands under the new Inflation Reduction Act.
Read More...
